202 related articles for article (PubMed ID: 25868975)
1. HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity.
Valente D; Bossi G; Moncada A; Tornincasa M; Indelicato S; Piscuoglio S; Karamitopoulou ED; Bartolazzi A; Pierantoni GM; Fusco A; Soddu S; Rinaldo C
Oncotarget; 2015 Apr; 6(12):10320-34. PubMed ID: 25868975
[TBL] [Abstract][Full Text] [Related]
2. HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody.
Rinaldo C; Moncada A; Gradi A; Ciuffini L; D'Eliseo D; Siepi F; Prodosmo A; Giorgi A; Pierantoni GM; Trapasso F; Guarguaglini G; Bartolazzi A; Cundari E; Schininà ME; Fusco A; Soddu S
Mol Cell; 2012 Jul; 47(1):87-98. PubMed ID: 22658722
[TBL] [Abstract][Full Text] [Related]
3. HIPK2 and extrachromosomal histone H2B are separately recruited by Aurora-B for cytokinesis.
Monteonofrio L; Valente D; Ferrara M; Camerini S; Miscione R; Crescenzi M; Rinaldo C; Soddu S
Oncogene; 2018 Jun; 37(26):3562-3574. PubMed ID: 29563611
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro.
Trapasso F; Aqeilan RI; Iuliano R; Visone R; Gaudio E; Ciuffini L; Alder H; Paduano F; Pierantoni GM; Soddu S; Croce CM; Fusco A
DNA Cell Biol; 2009 Apr; 28(4):161-7. PubMed ID: 19364276
[TBL] [Abstract][Full Text] [Related]
5. An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis.
Gatti V; Ferrara M; Virdia I; Matteoni S; Monteonofrio L; di Martino S; Diodoro MG; Di Rocco G; Rinaldo C; Soddu S
Cells; 2020 Feb; 9(2):. PubMed ID: 32093146
[TBL] [Abstract][Full Text] [Related]
6. HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.
Hofmann TG; Glas C; Bitomsky N
Bioessays; 2013 Jan; 35(1):55-64. PubMed ID: 23169233
[TBL] [Abstract][Full Text] [Related]
7. N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.
Yabuta N; Mukai S; Okamoto A; Okuzaki D; Suzuki H; Torigata K; Yoshida K; Okada N; Miura D; Ito A; Ikawa M; Okabe M; Nojima H
J Cell Sci; 2013 Jan; 126(Pt 2):508-20. PubMed ID: 23230145
[TBL] [Abstract][Full Text] [Related]
8. CDKL5 localizes at the centrosome and midbody and is required for faithful cell division.
Barbiero I; Valente D; Chandola C; Magi F; Bergo A; Monteonofrio L; Tramarin M; Fazzari M; Soddu S; Landsberger N; Rinaldo C; Kilstrup-Nielsen C
Sci Rep; 2017 Jul; 7(1):6228. PubMed ID: 28740074
[TBL] [Abstract][Full Text] [Related]
9. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.
Isono K; Nemoto K; Li Y; Takada Y; Suzuki R; Katsuki M; Nakagawara A; Koseki H
Mol Cell Biol; 2006 Apr; 26(7):2758-71. PubMed ID: 16537918
[TBL] [Abstract][Full Text] [Related]
10. HIPK2 Phosphorylates the Microtubule-Severing Enzyme Spastin at S268 for Abscission.
Pisciottani A; Biancolillo L; Ferrara M; Valente D; Sardina F; Monteonofrio L; Camerini S; Crescenzi M; Soddu S; Rinaldo C
Cells; 2019 Jul; 8(7):. PubMed ID: 31284535
[TBL] [Abstract][Full Text] [Related]
11. Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.
Feng Y; Zhou L; Sun X; Li Q
Oncotarget; 2017 Mar; 8(12):20452-20461. PubMed ID: 28107201
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
13. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
[TBL] [Abstract][Full Text] [Related]
14. Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis.
Ricci A; Cherubini E; Ulivieri A; Lavra L; Sciacchitano S; Scozzi D; Mancini R; Ciliberto G; Bartolazzi A; Bruno P; Graziano P; Mariotta S
J Cell Physiol; 2013 Jan; 228(1):235-41. PubMed ID: 22689412
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
Ohtsu N; Nobuhisa I; Mochita M; Taga T
Exp Cell Res; 2007 Jan; 313(1):88-97. PubMed ID: 17064687
[TBL] [Abstract][Full Text] [Related]
16. Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype.
Anzilotti S; Tornincasa M; Gerlini R; Conte A; Brancaccio P; Cuomo O; Bianco G; Fusco A; Annunziato L; Pignataro G; Pierantoni GM
Cell Death Dis; 2015 Dec; 6(12):e2004. PubMed ID: 26633710
[TBL] [Abstract][Full Text] [Related]
17. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
[TBL] [Abstract][Full Text] [Related]
18. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
[TBL] [Abstract][Full Text] [Related]
19. FLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperones.
Pan TL; Hsu SY; Wang PW; Cheng YT; Chang YC; Saha S; Hu J; Ouyang P
Cell Cycle; 2015; 14(8):1174-87. PubMed ID: 25751302
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
